Sheri,
treating her RA
with ACTEMRA
SC injections
Delaina,
treating her RA
with ACTEMRA
IV infusions
ACTEMRA IS FDA APPROVED
and available as an IV infusion and SC* injection
ACTEMRA was studied in 7 key clinical trials. In this section, you'll see the data for ACTEMRA IV infusions and SC injections.
SC injection clinical trial results IV clinical trial results
*A subcutaneous injection given under the skin.
SAFETY FIRST
Before reading more, please see the Important Safety Information for ACTEMRA.
Disease modifying antirheumatic drugs, or DMARDs, may slow or limit the progression of RA in some patients, saving joints and other tissues from permanent damage.
The treatment of a disease consisting of only one drug. For example, ACTEMRA can be used as a monotherapy treatment because it has been proven to work effectively without the use of additional DMARDs like methotrexate.
Interleukin-6, or IL-6, is a type of cytokine in the body with a wide variety of biological functions. People with RA may have more IL-6 in the areas surrounding the joints than any other cytokine.